First Time Loading...

Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 91.95 HKD 2.17% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Beigene Ltd

Wall Street analysts forecast Beigene Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beigene Ltd is 138.17 HKD with a low forecast of 122.06 HKD and a high forecast of 163.12 HKD.

Lowest Forecast
Wall Street Target
122.06 HKD
33% Upside
Average Forecast
Wall Street Target
138.17 HKD
50% Upside
Highest Forecast
Wall Street Target
163.12 HKD
77% Upside
Lowest
Price Target
122.06 HKD
33% Upside
Average
Price Target
138.17 HKD
50% Upside
Highest
Price Target
163.12 HKD
77% Upside
Beigene Ltd Competitors:
Price Targets
300676
BGI Genomics Co Ltd
154% Upside
1801
Innovent Biologics Inc
44% Upside
E
1952
Everest Medicines Ltd
3% Upside
B
BAVA
Bavarian Nordic A/S
90% Upside
300676
BGI Genomics Co Ltd
154% Upside
1801
Innovent Biologics Inc
44% Upside
E
1952
Everest Medicines Ltd
3% Upside
B
BAVA
Bavarian Nordic A/S
90% Upside
301047
Sino Biological Inc
47% Upside
KMDA
Kamada Ltd
138% Upside
S
096530
Seegene Inc
72% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
Beigene Ltd

For the last 3 years the compound annual growth rate for Beigene Ltd's revenue is 48%. The projected CAGR for the next 4 years is 34%.

48%
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Beigene Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Beigene Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beigene Ltd's stock price target?
Price Target
138.17 HKD

According to Wall Street analysts, the average 1-year price target for Beigene Ltd is 138.17 HKD with a low forecast of 122.06 HKD and a high forecast of 163.12 HKD.

What is Beigene Ltd's Revenue forecast?
Projected CAGR
34%

For the last 3 years the compound annual growth rate for Beigene Ltd's revenue is 48%. The projected CAGR for the next 4 years is 34%.

ALPHA SPREAD
Join more than 132,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.